← back to ideas

mRNA Vaccine Risk Assessment Platform

7.8
healthcare profitable added: Wednesday February 2026 11:56

A platform that analyzes FDA application reviews and related news sentiment, specifically regarding mRNA vaccines, identifying potential red flags and providing risk scores for vaccine developers and investors. It addresses concerns over agency hostility and aims to proactively mitigate risks.

180h
mvp estimate
7.8
viability grade
9
views

technology stack

Python PostgreSQL Medium

inspired by

FDA refuses to review Moderna's mRNA flu vaccine